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Adherence to anti-hypertensive medication: proposing and testing a conceptual model 
 
Abstract 
Objectives  A conceptual model of the psychological factors underpinning adherence to anti-
hypertensive medication is proposed and tested.  The model suggests that adherence is 
influenced by three sets of variables: demography, health status and perceived effects of 
medication; cognitions and motivation; and intention to adhere.   
 
Methods and Design  Patients with known hypertension were recruited from three primary 
care practices in South-East England and were asked to complete a postal questionnaire.  A 
total of 1070 responses were received.  The questionnaire asked about the three sets of 
predictor variables, and adherence.  Eight weeks after the first questionnaire, a second was 
posted to all respondents, this time asking about adherence over the intervening period.   
 
Results  The three sets of predictor variables were treated as blocks in a hierarchical model, 
so that each successive block added to the variance in adherence explained by the previous 
blocks.  The data were analysed by hierarchical multiple regression.  The predictors 
accounted for 19% of the variance in adherence at Time 1, and 34% at Time 2.  The leading 
individual predictors at Time 1 were age, gender, conscientiousness, hypertensive identity, 
perceived behavioural control, and intention.  At Time 2, they were the same, except that 
gender made way for adherence at Time 1. 
 
Conclusions  The model offers a parsimonious account, and the findings suggest a number of 
approaches to designing interventions to modify behaviour. 
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Adherence to Anti-Hypertensive Medication: A Conceptual Model 
Adherence and hypertension 
The term adherence refers to the following of treatment regimens as recommended by a 
healthcare provider (World Health Organization, 2003).  Two ‘types’ of non-adherence are 
usually described in the literature – intentional and unintentional.  Intentional non-adherence 
stems from a deliberate decision not to follow treatment recommendations, whereas 
unintentional non-adherence involves the failure to follow through intentions because of 
factors such as forgetting, physical inability to carry out instructions, or poor understanding 
of the regimen (Horne, 1997).   
Explanations for non-adherence tend to address intentional aspects of the behaviour 
rather than unintentional ones.  The adherence literature explains non-adherence by reference 
to a large number of demographic factors (Primatesta, Brookes, & Poulter, 2001): aspects of 
health care, such as patient/provider interaction, complexity of drug regimens and side effects 
of medication (Morisky & Ward, 2001; Weir et al., 2000); and patients’ knowledge and 
beliefs concerning the condition and treatment in question, such as perceptions of the 
condition (for example, Horne, 1997, 1999; Horne & Weinman, 1999, 2002; Legare, Godin, 
Dodin, Turcot, & Lapierre, 2003; Lynch et al., 2000; Schmier & Leidy, 1998; Trachtenberg, 
Dugan, & Hall, 2005).  Despite these explanations, the social-psychological mechanisms 
involved in medication adherence are poorly understood and no single conceptual framework 
has been developed in which to study it (Morrell, Park, Kidder, & Martin, 1997). 
The aim of the present study was to investigate the predictors of medication 
adherence by developing a conceptual model, using a prospective longitudinal design to 
investigate possible causal pathways.  This was pursued in the context of adherence to anti-
hypertensive medication.  We chose to study hypertension because it is a common condition 
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that is a risk factor for other potentially fatal conditions, such as myocardial infarction and 
stroke, and because blood pressure control in the UK is known to be sub-optimal -- even 
among those treated for hypertension, of whom only half to two-thirds are thought to be 
adherent (Ebrahim, 1998; Primatesta, Brookes, & Poulter, 2001).   
Hypertension is the term for the presence of consistently pathologically high blood 
pressure.  Currently, it is defined as blood pressure greater than 140/90 mmHg (UK 
Department of Health, 1999; Williams et al., 2004), although definitions vary across 
countries (Wolf-Maier et al., 2004).  It may be primary (termed ‘essential hypertension’) or 
secondary.  Secondary hypertension arises as a consequence of another disease process, such 
as renal disease, whereas essential hypertension exists in its own right.  Treatment is usually a 
combination of diet/exercise modification and medication.  All the common medications have 
side effects (Colledge, Walker & Ralston, 2010), and managing hypertension medically is not 
guaranteed to maintain blood pressure within the desired range.  The current recommended 
treatment is multiple drugs, to be taken once a day (Williams et al., 2004).  Whilst medication 
may occasionally require adjustment in order to achieve control, a well-managed programme 
of treatment to which the patient adheres is more likely to succeed than continual alteration of 
drug regimens. 
Research suggests that approximately three-quarters of poor blood pressure control 
could be attributable to poor adherence (Morisky & Ward, 2001).  It has been estimated that, 
within the first year of diagnosis, up to 50% of patients prescribed anti-hypertension agents 
discontinue their medication, or do not fully adhere to the regimen recommended by their GP 
(Ebrahim, 1998; Flack, Novikov, & Ferrario, 1996).  Ebrahim (1998) conducted a 
comprehensive systematic review of the hypertension literature, from which he concluded 
that barriers to adherence were likely to be related to factors such as medication side effects, 
over-complex medication regimens, and ‘unhelpful’ health beliefs. 
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Predictors of adherence to hypertension medication 
Although there is as yet no integrated model of adherence to hypertension medication, a 
number of individual predictors have nevertheless been identified.  Moreover, research on 
other medical treatment regimens, and on protective health behaviours, offers further 
indications.  The variables can be considered in three groups: demography, health status, and 
medication; cognitions and motivation; and behavioural intentions.   
Demography, health status and medication regimen 
The influence of demographic factors in health, such as age, marital status, and education, is 
well documented.  For example, morbidity varies by ethnic group, and is raised in people 
from lower socio-economic groups, and those who have received fewer years of education 
(Marmot & Davey Smith, 1997).   Adherence rates also tend to be lower in these groups 
(Taylor, 2006), not least for hypertension (Primatesta, Brookes, & Poulter, 2001).  
Hypertension itself is more common in older people, and is often associated with other health 
problems. 
A well established factor in poor adherence is the side effects that medication 
produces.  The literature reports a strong tendency for those who experience side effects to 
omit doses or to discontinue medication altogether.  For example, Weir et al. (2000) 
identified a low tolerance for a range of side effects.  Of their sample, 33% reported that they 
would not take a medication prescribed for hypertension if it caused fatigue, 51% if it made 
their face swell, and 42% if they developed a cough.  Moreover, 58% would discontinue if 
the drug caused dizziness and 60% if they developed a rash.  Whilst these are not the most 
common side effects, cough, frequency of micturition, dizziness and fatigue are all well-
documented (Williams et al., 2004).  Experiencing side effects influences beliefs about the 
costs and benefits of medication adherence: where a person perceives that the costs of 
adherence outweigh the benefits, adherence rates tend to fall (Horne & Weinman, 1999).   
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Cognitions and motivation 
Beliefs and attitudes  The literature indicates that patients are aware of – and 
concerned about – the risks of uncontrolled hypertension.  However, many patients believe 
that it is possible to tell whether or not one’s blood pressure is raised, and intentionally 
discontinue medications that cause side effects (Meyer, Leventhal, & Guttman, 1985; Weir et 
al., 2000).  Consistent with Horne & Weinman’s work, those who describe medication-
related relief of symptoms exhibit greater adherence and better control, suggesting that 
patients develop implicit models or beliefs that drive their adherence behaviour, and that their 
beliefs are related to the experienced severity of the disorder (Baumann, Cameron, 
Zimmerman, & Leventhal, 1989; Scisney-Matlock & Watkins, 2003).   Perception of serious 
consequences of a condition exerts both a direct effect upon adherence and an indirect effect 
via treatment beliefs, suggesting that, if people perceive severe consequences of their disease, 
they will be more likely to see the need for treatment and so to adhere (Horne & Weinman, 
2002).  It has also been shown that simple failure to understand one’s treatment regimen may 
lead to unintentional non-adherence, through forgetting or carelessness (Casey, Johnson, & 
McClelland, 2003).  A further factor is the perceived pressure to adhere that people 
experience from their salient others, which Ajzen (2002) and Ajzen & Fishbein( 2005) in the 
Theory of Planned Behaviour call subjective norm. 
Perceived control and self-efficacy  Both perceived control and self-efficacy, which 
combine to make perceived behavioural control in the Theory of Planned Behaviour, are 
known to predict adherence to health-protective regimens - in, for example, haemodialysis 
(Christensen, Moran, Lawton, Stallman, & Voigts, 1997), anti-retroviral therapy (Godin, 
Côté, Naccache, Lambert, & Trottier, 2005), cardiac rehabilitation exercise programs 
(Woodgate, Brawley, & Weston, 2005), cholesterol-lowering diets (Burke, Dunbar-Jacob, 
Orchard, & Sereika, 2005), self-care for diabetes (Murphy, Thompson, & Morris, 1997; 
Adherence to anti-hypertensive medication 
7 of 32 
O'Hea, 2005; Williams & Bond, 2002), and exercise in the healthy population (McCaul, 
Sandgren, O'Neill, & Hinsz, 1993).  Strong senses of self-efficacy and perceived control are 
known to predict greater adherence (McCauley, 1993; Robertson & Keller, 1992). 
Hypertensive self-identity  Another predictor is self identity.  Self-identity both 
predicts intentions (Armitage & Conner, 1999) and mediates the intention-behaviour 
relationship (Sheeran & Orbell, 2000).  It has been found to predict intention independently 
of attitude for the consumption of organic foods (Sparks & Shepherd, 1992) and 
independently of prior behaviour for household recycling, suggesting that it is not merely a 
function of habitual action (Terry, Hogg, & White, 1999).  Terry’s prospective study 
demonstrated that self-identity predicted intention but not behaviour, something that has been 
confirmed by Conner & McMillan (1999) for cannabis use. 
Hypertensive Self-Identity (HSI) reflects the degree to which a person sees being a 
hypertensive patient as positive or negative.  If, for example, I see myself as someone who 
follows my doctor's advice, I may strive to maintain this identity through my behaviour, and  
my behaviour will be reinforced and will be predicted more strongly as time goes on (Charng, 
Piliavin, & Callero, 1988; Conner & Armitage, 1998).   HSI has received little attention so 
far, but the available evidence suggests that it plays a part in adherence (Baumann, Cameron, 
Zimmerman, & Leventhal, 1989; Meyer, Leventhal, & Guttman, 1985).  Three components 
of HSI can be distinguished -- the symptoms that individuals report, the illness label they give 
their problem, and how they monitor their illness.  All three are likely to influence intention 
to adhere, and so adherence itself.  
Conscientiousness  One final predictor in this group is conscientiousness, the degree 
to which a person is organized, hardworking and careful.  People high on this trait may be 
expected to make more of an effort to follow medical advice.  Evidence from health 
behaviours suggests that the factor does predict adherence to medical regimens – in renal 
Adherence to anti-hypertensive medication 
8 of 32 
dialysis, for example (Christensen & Smith, 1995), and cholesterol-lowering treatment 
(Stilley, Sereika, Muldoon, Ryan, & Dunbar-Jacob, 2004)  – and it may even predict 
longevity (Friedman, Tucker, Schwartz, & Martin, 1995).  At the time of writing in 2010, 
there is as yet no published work on hypertension, so far as we know. 
Behavioural intentions 
Behavioural intentions are generally regarded as the proximal and strongest predictors 
of behaviour (for example, Ajzen, 2002, Ajzen & Fishbein, 2005).  Among the health 
behaviours to have been examined are smoking (Godin, Valois, Lepage, & Desharnais, 
1992), breast feeding (Duckett et al., 1998), medical screening (Norman & Conner, 1993; 
Rutter, 2000; Steadman & Rutter, 2004), food choice (Conner, Povey, Bell, & Norman, 1994; 
Sparks & Shepherd, 1992) and condom use (Chan & Fishbein, 1993).  According to the most 
frequently used approached to intention, the Theory of Planned Behaviour (Ajzen, 1991, 
2005), intention to adhere to hypertension medication will be best predicted by the person’s 
attitude to adhering, subjective norm about adhering, and perceived behavioural control over 
adhering – variables that were noted earlier in the Introduction.  Attitude is a ‘summary 
statement’ of the person’s beliefs for or against doing the behaviour and the consequences of 
it.  Subjective norm comes from beliefs about what others want us to do and our motivation 
to comply with those wishes.  Perceived behavioural control is concerned with the perceived 
presence or absence of internal or external factors that may facilitate or hinder performance 
of the behaviour.  It is through the mediation of intention that the ‘more distal’ predictors of 
behaviour have their effects.  It has also been suggested that the predictive power of intention 
might be moderated by how certain we are of our intentions (Sheeran & Abraham, 2003, 
Cooke & Sheeran, 2004). 
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Deriving a conceptual model of adherence to hypertension medication 
The purpose of our paper is to provide an exploratory framework for what we believe is the 
first attempt to predict adherence to hypertension medication from a knowledge of 
individuals’ intentions, cognitions and motivations, and demographic and medical 
backgrounds.  Others have considered similar variables in health behaviour – see, for 
example, the discussion of ‘social ecology’ and ‘personality’ in Kaplan & Simon (1990), and 
the model social psychological mediators of the relationship between demographic factors 
and health outcomes in Rutter & Quine (1996).  Our approach in the present paper sees the 
sets of variables as contributing hierarchically.  Thus, demographic and health status 
variables are the most distal predictors of adherence, but will nevertheless make a noticeable 
contribution of their own; the second block of variables is those we have called cognitions 
and motivation; and intentions are the third.  We predict that each level of the hierarchy will 
add significantly to the variance explained. 
Method 
Participants and procedure 
The study was a longitudinal questionnaire survey.  Following NHS Research Ethics 
approval, three Primary Care Practices (PCPs) in the South-East of England were approached 
and agreed to distribute 1784 questionnaire packs to surgery-registered patients with 
hypertension.  The three PCPs covered rural, coastal and urban areas, reflecting the 
geographical characteristics of the area in question. The packs were made up and sealed by 
the researchers, and the surgery staff addressed and posted the envelopes.   Practice staff 
identified registered hypertensive patients from surgery-maintained computerized records.  
The packs were delivered to each PCP in sealed envelopes, ready for address labels generated 
from the computerized search to be attached.  They contained a covering letter, a patient 
information sheet describing the study and requirements for participation, two copies of a 
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consent form (one to return and one to keep), an address sheet for patients to record their 
name and address so that they could receive a follow-up questionnaire, and a copy of the first 
questionnaire.  A reply-paid envelope addressed to the University was enclosed.  Patients 
who consented to participate returned the consent form and the completed questionnaire, 
along with their names and addresses. A brief second questionnaire was sent eight weeks 
later to all those who responded.   
Measures 
The Time 1 questionnaire contained measures of adherence and the three sets of 
predictor variables.  Adherence was measured by an augmented version of the four-item scale 
developed by Morisky, Green, & Levine (1986).  Items were scaled from (1) always to (5) 
never:  “Do you ever forget to take your blood pressure tablets?”, “Are you careless about 
taking your tablets?”, “When you feel better, do you stop taking your tablets?”, and “If you 
feel worse when you take your blood pressure tablets, do you stop taking them?”.  To the four 
original items we added a fifth, because pilot respondents indicated that it was an important 
index of non-adherence: “Have you ever missed an appointment to see your doctor or nurse 
about your high blood pressure?”.  Reliability was assessed by Cronbach’s alpha, and the 
value for the five-item scale was 0.66.  Alpha for the four original Morisky items was 0.65 
(against 0.61 in the Morisky, Green & Levine study).     
Demography, health status and medication regimen 
The measures of demography were gender, age, educational attainments, and socio-
economic status (using the proxy measure of car availability from the UK Office of National 
Statistics).  The measures of health status consisted of a five-point scale of self-rated general 
health, from (1) very bad to (5) very good; ten items on existing risk factors relating to 
hypertension  - diabetes, stroke, angina, heart attack, heart murmur, abnormal heart rhythm, 
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and other heart trouble - and any medical treatment received for them; and corresponding 
items on risk factors in the patient’s family.  To provide information on medication regimen, 
participants were asked the names of their drugs, how frequently they took them each day, 
and when they were first prescribed. 
Cognitions and motivation 
The first measures in this section of the questionnaire were the predictors of 
behaviour identified  by the Theory of Planned Behaviour (Ajzen, 1991, 2005): participants’ 
attitude to taking the medication, their subjective norm about the behaviour, and their 
perceived behavioural control over carrying out the behaviour.  The measures were direct, 
rather than derived indirectly from underlying beliefs (Ajzen, 2002; Ajzen & Fishbein, 2005; 
Montano, Kasprzyk, von Haeften, & Fishbein, 2001).  For attitude there were five items, all 
based on the stem, “Taking my blood pressure tablets every day is…”: “extremely foolish” 
(1) to “extremely wise” (5);  “extremely harmful” (1) to “extremely beneficial” (5); 
“extremely unpleasant” (1) to “extremely pleasant” (5); “extremely inconvenient” (1) to 
“extremely convenient” (5); and “extremely worrying” (1) to “extremely reassuring” (5).  
Reliability was assessed by Cronbach’s alpha, and the value was 0.70.  The five scores were 
averaged to produce a single value.  Subjective norm was the product of two items: “Most 
people who are important to me would approve of my taking my blood pressure tablets 
everyday”, scored from (1) strongly disagree” to (5) “strongly agree”, multiplied by “I feel 
under social pressure to take my blood pressure tablets every day”, scored from (1) “strongly 
disagree” to (5) “strongly agree”.   For perceived behavioural control (PBC), there were three 
items:  “How much personal control do you feel you have over taking your blood pressure 
tablets every day?”, scored from (1) “no control” to (5) “complete control”; “For me to take 
my blood pressure tablets every day would be …” (1) “extremely difficult” to (5) “extremely 
easy”; and “Whether or not I take my blood pressure tablets every day is entirely up to me”, 
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scored from (1) “strongly disagree” to (5) “strongly agree”.  The items were summed to 
produce a total score. 
A further set of five questions, adapted from Sheeran & Orbell (2000), measured 
hypertensive self-identity:  “I am a person who cares about my health and high blood 
pressure”, “I am disciplined at taking my high blood pressure tablets”, “I am concerned about 
the long-term benefits of taking my blood pressure tablets”, “I am successful at taking my 
prescribed blood pressure tablets”, and “I think about the consequences for my family with 
regard to taking my blood pressure tablets”.  All the items were scored (1) “Disagree 
strongly” to (5) “Agree strongly”.  Cronbach’s alpha was 0.77, and the items were summed to 
produce a total score. 
Conscientiousness was measured by the ten-item conscientiousness scale taken from 
the International Personality Item Pool (Goldberg et al., 2006).  The items were scored from 1 
(“very inaccurate”) to 5 (“very accurate”) and were as follows: “I”… “am always prepared”, 
“pay attention to details”, “get jobs done right away”, “like order”, “follow a schedule”, “am 
exacting in my work”, “leave my belongings around”, “make a mess of things”, “shirk my 
duties”, and “forget to put things back in their proper place”.  Cronbach’s alpha was 0.83, and 
the items sere summed to produce a total score. 
Finally in this section of the questionnaire, knowledge about hypertension was 
measured by a 15-item scale devised by the authors.  The scale was designed to represent 
common lay ‘medical’ beliefs about hypertension.  With the rest of the questionnaire, it was 
piloted with samples of patients with hypertension.  The 15 items were: “A person can always 
tell when they have high blood pressure”, “Too much exercise is related to high blood 
pressure”, “Another name for high blood pressure is hypertension”, “Doctors tell people with 
high blood pressure to eat more salty foods”, “Sometimes the doctor changes tablets for some 
people”, “People with high blood pressure are told not to exercise and stay in bed more”, 
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“There are different kinds of blood pressure tablets”, “Smoking cigarettes and cigars lowers 
blood pressure”, “Some people feel worse when they first start taking tablets for high blood 
pressure”, “Being overweight is related to high blood pressure”, “Being underweight is 
related to high blood pressure”, “Having too much salt in the diet is related to high blood 
pressure”, “High blood pressure runs in the family”, “High blood pressure can cause cancer”, 
and “High blood pressure can cause tuberculosis”.  Items scored 1 for correct and 0 for 
incorrect, and Cronbach’s alpha for the scale was 0.70. Items were summed to produce a total 
scale score. 
Intentions 
Intentions were measured by four questions, the first three scored from (1) “strongly 
disagree” to (5) “strongly agree”, the last one from (1) “very unlikely” to (5) “very likely”.  
The questions were: “I intend to take my blood pressure tablets every day”, “I plan to take my 
blood pressure tablets every day”, “I want to take my blood pressure tablets every day”, and  
“How likely is it that you will take your blood pressure tablets every day?”.  Cronbach’s 
alpha was 0.85, and the items were summed to produce a total score.  Since a number of 
writers have suggested that the link between intention and behaviour is moderated by how 
sure a person is about his or her intentions (see the meta-analysis by Cooke & Sheeran, 
2004), intention certainty was also measured: “My intention to take my blood pressure tablets 
every day is…” (1) “very uncertain” to (5) “very certain”.  The total score for intention was 
multiplied by the score for intention certainty to give a single combined measure. 
Time 2 questionnaire 
The second questionnaire repeated the five questions used at Time 1 to measure adherence. 
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Results 
Preliminary analyses 
Of the 1784 patients approached, 1070 (60%) responded at Time 1 and 934 of those met the 
study’s inclusion criteria.  The two main reasons for exclusion were not being on prescribed 
medication and being too elderly or infirm to complete the questionnaire (for example, living 
in a nursing home or residential home).  Over half of participants (57.5%) were female, 42% 
were male, and the remainder (0.5%) failed to say.  Mean age was 69.0 years (SD 11.7), with 
men (69.6 years) slightly older than women (68.8 years).  Just over 75% of participants who 
responded at Time 1 returned a Time 2 questionnaire, and there was a significant attrition 
difference between genders, with 27.9% of women and 20.4% of men dropping out of the 
study.  The majority of participants (67.8%) were married or living with a partner (80.3% of 
men but only 58.7 of women), and 32.2% lived alone.  General health did not differ between 
the sexes: 62.1% of men and 57.9% of women reported good general health, and only 7.5% 
of men and 5.5% of women reported poor health.  Significantly more men (87.4%) than 
women (64.7%) had permanent access to a car.  Almost half the participants revealed no 
details of their education but, of those who did, there was again a significant difference 
between the sexes, with men more likely than women to have achieved qualifications in all 
the categories listed, except GCE ‘O’ level -- a reflection, perhaps, of the average age of the 
participants. 
Medication 
Almost 50% of participants had been on prescribed medication for six years or more.  The 
vast majority (86%) took their principal medicine once a day, and fewer than 5% had a 
regimen of more than four times a day.  Only 146 patients (15.6%) reported side effects, 
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some of which may not have been attributable to the medication.  Just over 5% (55) reported 
two or more concurrent side effects, but the majority reported just one, if any. 
Medical and genetic risk factors 
In total, 27% (249) of patients were receiving current treatment for a heart condition.  Most 
participants had relatively few medical risk factors for stroke and CHD, other than their 
hypertension, though some were unsure whether they had ever suffered from the conditions 
stated.  The most common genetic risks factors were having a parent with hypertension or 
one who had had a heart attack or stroke.  The percentages, measure by measure, averaged 
15% to 20%, but as many as 40% of respondents did not know their parents’ histories. 
Intention and adherence 
The measure of intention was highly skewed.  For example, in answer to the item ‘Do you 
intend to take your blood pressure tablets every day in the future’,  63.5% answered that they 
intended to do so ‘always’ and 33.2% answered ‘most of the time’.  The distribution of 
adherence scores at both time points was also highly skewed, the majority of participants 
reporting almost full adherence.  Completion of all adherence scale items yielded a score 
between 5 and 25 for each participant.  At Time 1, only 0.8% (7) of participants scored 15 or 
below, 8.2% (76) scored 20 or below, and 44% (413) scored 24 or below.  At Time 2, the 
figures were 0.9% (6), 5.6% (39) and 43.3% (305) respectively. 
Predicting intention and adherence 
Zero order correlations between predictors and outcome are given in Table 1.  The first group 
of predictors revealed a number of statistically significant relationships with outcome, but 
there were many more for the second group, cognitions and motivation.  In the final group, 
intention, intention certainty, and their product all correlated significantly with adherence at 
both Time 1 and Time 2. 
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Table 1 
 The second set of analyses used multiple regression, to predict the three principal 
outcomes: intention at Time 1, adherence at Time 1, and adherence at Time 2.  A hierarchical 
approach was employed, so that each block of predictor variables was entered in turn, and the 
increment in variance explained by successive blocks was extracted.  The results are given in 
Table 2.  For intention, the first block of predictors (demography, health status and 
medication regimen) accounted for 4% of the variance  (adjusted).  The second block 
(cognitions and motivation) added a further 31%, giving 35% altogether.  For Time 1 
adherence, the increment from the first block to the second was again marked, 4% to 15%.  
The variance added by the final block (intention x intention certainty) was 4%, giving 19% in 
total.  For Time 2 adherence, Time 1 adherence was entered as a first block, to control for 
baseline behaviour and so to allow change in behaviour from Time 1 to Time 2 to be 
examined.  The remaining blocks were identical to those used in the analysis of Time 1 
adherence.  Much the largest contribution came from adherence at Time 1, and the four 
blocks together accounted for 34% of the variance.  Standardised beta coefficients for the 
statistically significant predictors of outcome are given in Table 3.  The values are taken from 
the final models, after the concluding block had been entered. 
Tables 2 and 3 
 In a further analysis of the predictors of Time 1 adherence, regression-based path 
analysis was used to identify pathways from individual variables to adherence.  The variables  
were the six significant predictors shown in Table 3 – gender, age, conscientiousness, 
hypertensive identity, perceived behavioural control, and intention x intention certainty.  
Gender dropped out, and the final pattern of pathways is shown in Figure 1.  All predictors 
had direct pathways to adherence; conscientiousness, perceived behavioural control, and 
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hypertensive identity were also mediated by intention x intention certainty; and some of the 
effect of age was mediated through  perceived behavioural control and hypertensive identity. 
Figure 1 
 In a final set of analyses, we examined the distinction between intentional and 
unintentional non-adherence introduced at the beginning of the paper.  Of the four indices in 
the Morisky, Green & Levine (1986) scale, forgetting to take one’s medication and being 
careless about it are indices of unintentional poor adherence, while stopping medication if 
one feels better or worse reflects intentional behaviour.  For each component, hierarchical 
multiple regression was used as before.  Table 4 gives the final model summaries, and shows 
that the strongest predictions were for unintentional poor adherence: adjusted R2 was .16 for 
both forgetting and carelessness.  Table 5 gives the significant predictors from the final block 
of each analysis.  The strongest predictors of unintentional non-adherence were age, 
hypertensive identity, and intention x intention certainty; for intentional non-adherence the 
single, strong, predictor was intention x intention certainty.   
Tables 4 and 5  
Discussion 
Model and findings 
The purpose of this paper has been to propose and test a model of adherence to anti-
hypertensive medication.  The model incorporates three blocks of possible predictors, which 
are seen as having their effects hierarchically: demography, health status and medication 
regimen; cognitions and motivation; and intentions.  The variance explained in predicting 
adherence at Time 1 increased block by block as predicted and, when adherence was re-
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examined at follow-up, much the strongest predictor was adherence at Time 1, as is typically 
found across a wide range of behaviours (Conner & Norman, 2005; Ouellete & Wood, 1998).   
When the blocks were ‘unlocked’, and their individual components were examined, 
the single demographic variable to emerge as a significant predictor of adherence was age: 
the older the person, the greater the adherence.  The key components of cognitions and 
motivation were conscientiousness, perceived behavioural control, and hypertensive identity 
– and both perceived behavioural control and hypertensive identity were predicted by age, 
again positively.  All three of the variables predicted intention x intention certainty, which in 
turn was the strongest predictor of adherence.  The ‘profile’ of the most adherent person is 
thus someone who is older, is conscientious, believes that he or she is able to deal with 
potential barriers to adherence, and has a well developed identity as someone with 
hypertension.  Together, the variables lead to strong, resolute intentions.  The pattern offers 
some support to the suggestion from Ebrahim (1998), that ‘unhelpful’ health beliefs will be 
among the leading predictors of poor adherence.  
Although non-adherence has generally been examined as a single, composite measure, 
conceptually there are two underlying components, as we have noted: intentional and 
unintentional non-adherence.  We may, for example, choose not to take our medication 
(intentional), or we may forget to take it (unintentional).  Both forgetting and carelessness 
were predicted more strongly than stopping when one felt better or worse, and the model was 
therefore more successful with unintentional than intentional non-adherence.  The variables 
that distinguished most strongly were age and hypertensive identity: forgetting and 
carelessness were predicted by relative youth and an ill-formed hypertensive identity, while 
intentional non-adherence was predicted by neither. 
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Limitations of the study 
There are three main limitations to our findings.  The first is that outcome was measured by 
self-report.  Whilst the evidence indicates that self report measures are reliable (for example, 
Haynes et al., 1980; Morisky, Green, & Levine, 1986), they are known to over-estimate  
adherence (for example, Garber, Nau, Erickson, Aikens, Lawrence, 2004; Kaplan & Simon, 
1990) when compared with ‘objective’ measures, such as pill counting, prescription 
collection and filling, and electronic monitoring.  However, as the reviews by Osterberg & 
Blaschke (2005) and Hawkshead & Krousel-Wood (2007) make clear, objective measures 
can be expensive, time-consuming, intrusive, and even invasive (for example, tracking serum 
levels of medication – see Jónsdóttir et al., 2010).  There can also be questions of validity: 
throwing away tablets, making up for missed inhaler doses by discharging them into the air, 
and failing to fill collected prescription forms (Levine et al., 2006; Osterberg & Blaschke, 
2005).  In the event, the medical practices and ethics committee we worked with would not 
allow us to use these methods, principally because of the burden they would have placed on 
doctors, and self-report was the one technique available to us. 
 The self-report measure we chose is widely used (especially though not exclusively in 
hypertension), has reasonable reliability across studies, and is supported by published 
evidence of validity.  For example, Morisky, Green & Levine (1986) themselves 
demonstrated concurrent and predictive validity with hypertensive patients: the scale 
predicted control over hypertension both in the present and three years later.  Krapek et al., 
(2004) reported concurrent validity for the Haemoglobin A1c index of control in Type II 
diabetes, and Schnitzler, Leffers & Häck (2010) have recently demonstrated concurrent 
validity in treatment for Parkinson’s Disease.  Self-report questionnaires in general have been 
found to be more concordant with objective measures than other self-report measures, such as 
interviews (see, for example, Garber, Nau, Erickson, Aikens, Lawrence, 2004).  Thus, even if 
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the Morisky scale and similar measures over-estimate adherence, good concordance with 
objective measures means that the rank order of respondents will be the same for both 
approaches.  Rank-order is the principal interest in the present paper, since our main concern 
has been patterns of correlation between predictors and adherence – not absolute levels of 
adherence.  The evidence suggests that, for detecting those patterns, the  self-report measure 
we used is adequate.
 
The second point concerns the use of postal questionnaires.  One of the problems 
facing researchers who collect data in this way is that individuals who adhere are the most 
likely to respond (for example, Vaile, Calnan, Rutter & Wall, 1993).   A substantial minority 
of patients sent the first questionnaire did not respond to it.  Though it is likely that many of 
them were also not adhering fully to treatment, for reasons of ethics we were not allowed 
access to patients’ home addresses or medical records, and we have no way of testing the 
suggestion.  Other researchers are known to have experienced similar problems in attracting 
non-adhering patients into studies of this nature (Jackson et al., 2005).  
The final point is that adherence was greater than the literature typically suggests 
(Ebrahim, 1998; Nabi et al., 2008; Primatesta et al., 2001), perhaps in part because the 
sample was mostly elderly.  The age distribution reflects the geographical location and 
demographic makeup of the general practices that agreed to take part.  Though the upshot 
was less variance to explain than anticipated, identifiable patterns of prediction emerged 
nevertheless. 
Designing interventions to strengthen adherence 
Central to our pattern of findings is the role of cognitions and motivation.  While the 
intentions block added significantly to the prediction of behaviour, cognitions and motivation 
provide the underpinnings for intentions, and offer a useful means of intervention (Ajzen, 
1991; Ajzen & Fishbein, 2005).  Motivating people to acknowledge that the consequences of 
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poorly treated hypertension can be serious, indeed life-threatening, is central to strengthening 
both their conscientiousness and their identity as someone with hypertension.  Motivational 
interventions should be particularly effective for intentional non-adherence – choosing not to 
take one’s medication, because one fails to acknowledge its importance or is not sufficiently 
conscientious to follow a strict regimen. 
A second approach suggested by our results is through perceived control, and is 
perhaps best seen as intervening to strengthen cognitions.  Perceived behavioural control, as 
conceptualised by Ajzen (1991), is made up of both self-efficacy (the internal means to carry 
out a behaviour) and perceptions of barriers (the number and extent of anticipated external 
obstacles to carrying out the behaviour).  Thus, low perceived behavioural control is present 
when I believe that I shall be unable to keep to a routine and when the number and extent of 
the barriers I foresee are too great.  Here, a useful approach will be the planning interventions 
incorporated in implementation intentions interventions (Gollwitzer, 1999).  Patients are 
asked to list obstacles that might prevent them keeping to their prescribed regimen, to think 
of how they will overcome them, and to write down the plan.  The approach has had a degree 
of success in modifying a range of health behaviours (Sheeran, Milne, Webb & Gollwitzer, 
2005), but has yet to be tested in people with hypertension. 
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Table 1  Zero order correlations (r)  between predictors and outcome 
 
 
 Intention Adherence at Time 1 
Adherence at 
Time 2 
Gender -.03 -.06 -.03 
Age .08* .19*** .21*** 
Marital status .03 .03 .03 
Car ownership .05 -.08* -.03 
Health status .06 -.03 -.02 
Years on medication .09** .10** .01 
Daily dosage -.01 .04 .05 
Perceived side effects -.16*** -.09** -.08* 
Medical risk factors -.01 .07* .02 
Family risk factors .05 -.01 -.02 
    
Conscientiousness .22*** .18*** .11** 
Hypertensive identity .44*** .31*** .26*** 
Knowledge .09** -.04 -.08* 
Attitude .41*** .20*** .20*** 
Subjective norm .43*** .18*** .17*** 
PBC .33*** .24*** .10** 
    
Intention 1.00 .32*** .24*** 
Intention certainty .66*** .38*** .33*** 
Intention x certainty .92*** .35*** .30*** 
Adherence at Time 1 .32*** 1.00 .57*** 
 
Pairwise deletion: n ranges from 537 to 921 
 
*p<.05  **p<.01  ***p<.001 
Adherence to anti-hypertensive medication 
28 of 32 
Table 2  Model summaries for prediction of intention and adherence 
 
Model R2 Adj R2 R
2
 
change F change df1 df2 
Sig F 
change 
Time 1 Intention 
1 .05 .04 .05 3.9 10 682 p<.001 
2 .36 .35 .31 55.0 6 676 p<.001 
Time 1 Adherence 
1 .06 .04 .06 4.1 10 682 p<.001 
2 .17 .15 .12 16.0 6 676 p<.001 
3 .21 .19 .03 28.1 1 675 p<.001 
Time 2 Adherence 
1 .32 .32 .32 253.4 1 535 p<.001 
2 .34 .33 .02 61.7 10 525 ns 
3 .36 .34 .02 2.2 6 519 p<.05 
4 .37 .34 .01 4.7 1 518 P<.05 
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Table 3  Standardised beta coefficients from final models for each outcome 
 
 
 
Standardised 
Beta t 
 
Zero order 
correlation 
 
Partial 
correlation 
 
Semipartial 
correlation 
 
Intention at Time 1      
Side effects -.12 3.61** -.16 .14 -.11 
Hypertensive identity .23 6.18*** .44 .23 .19 
Knowledge .08 2.42* .09 .09 .07 
Attitude .17 4.70*** .41 .18 .14 
Subjective norm .23 6.22*** .43 .23 .19 
PBC .17 5.28*** .33 .20 .16 
Adherence at Time 1      
Gender -.08 -2.05* -.06 -.08 -.07 
Age .12 2.85** .19 .11 .10 
Conscientiousness .10 2.59** .18 .10 .09 
Hypertensive identity .14 3.30** .31 .13 .11 
PBC .11 3.05** .24 .12 .10 
Intention x certainty .24 5.31*** .35 .20 .18 
Adherence at Time 2      
Age .14 3.17** .21 .14 .11 
Years on medication -.09 -2.34* .01 -.10 -.08 
PBC -.08 -2.16* .10 -.09 -.08 
Intention x certainty .10 2.16* .30 .10 .08 
Time 1 adherence .52 13.09*** .57 .50 .46 
 
p<.05  ** p<.01  ***p<.001 
 
Coefficients for predictors that failed to reach statistical significance are not shown 
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        Table 4  Model summaries for prediction of individual measures of adherence at Time 1 
 
 
 R2 Adj R2 df1 df2 F Sig 
Forget .18 .16 17 675 8.9 p<.001 
Careless .18 .16 17 675 9.0 p<.001 
Stop if feel better .15 .13 17 675 6.9 p<.001 
Stop if feel worse .08 .06 17 660 3.4 p<.001 
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Table 5  Standardised beta coefficients from final model for individual adherence measures at 
Time 1 
 
 
 Unintentional Intentional 
 Forget Careless Stop if feel better 
Stop if feel 
worse 
Gender .00 -.03 -.01 .06 
Age -.24*** -.15*** .01 -.04 
Years on medication .05 .00 -.04 -.06 
Perceived side effects .00 .07* .09* .05 
Conscientiousness -.07 -.07* -.02 -.03 
Hypertensive identity -.14** -.20*** -.09 -.03 
Knowledge .05 .04 .10* .04 
Subjective norm .02 .04 .10 .05 
PBC -.06 -.04 .03 -.05 
Intention x certainty -.18*** -.16*** -.33*** -.21*** 
 
*p<.05  **p<.01  ***p<.001 
 
Coefficients for predictors that failed to reach significance for any of the five measures of 
adherence are not shown
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Figure 1  Path diagram for predictors of attendance at Time 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coefficients are standardised beta coefficients  *p<.05  ** p<.01***p<.001 
 
Adjusted R2 0.18,  F (4, 694) = 32.28  p<.001 
 
    
 
 
 
Age Hypertensive Identity
Intention x Certainty Adherence
at Time 1
Conscientiousness
.13***
.23***
.
41*
**
.07
*
.16***
.08*
Perceived
Behavioural Control .24***
10*
*
.10**
.13**
 
 
